Product Information

DICLOXACILLIN 250 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.5844 per EA under NDC 00093312301. Its NADAC has been published 630 times since Nov 28, 2013.

FDA first approved this application on Jun 3, 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DICLOXACILLIN 250 MG CAPSULE

Dicloxacillin Sodium
$0.5844per EA

Strength

250 mg/1

NDC

00093312301

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DICLOXACILLIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA062286

FDA Approved

6/3/1982

TE Code

AB

On Market Since

9/30/1990

Pharmacological Classes

Price Statistics

The NADAC for DICLOXACILLIN 250 MG CAPSULE has been published 630 times since Nov 28, 2013, and over the history we have for it it has risen 169.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5844 per EA
All-time high$0.6096 (Oct 16, 2019)
All-time low$0.2167 (Nov 28, 2013)
52-week high$0.6071
52-week low$0.5421
Median price$0.4706
Average price$0.4362
Largest weekly change+59.7% (Jul 20, 2016)
Weeks tracked630
Tracking sinceNov 28, 2013

Price History

1W

+1.2%

1M

+1.2%

3M

+1.8%

6M

+7.5%

1Y

-3.7%

3Y

+6.5%

5Y

+19.6%

All

+169.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dicloxacillin Sodium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of DICLOXACILLIN 250 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DICLOXACILLIN 250 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $0.5844 per EA (NDC 00093312301), effective Aug 19, 2026.

How has the price of DICLOXACILLIN 250 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DICLOXACILLIN 250 MG CAPSULE has risen 169.7%. It has been tracked across 630 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DICLOXACILLIN 250 MG CAPSULE?

Since Nov 28, 2013, the NADAC for DICLOXACILLIN 250 MG CAPSULE has ranged from a low of $0.2167 (Nov 28, 2013) to a high of $0.6096 (Oct 16, 2019), with a median of $0.4706 per EA.

Are there cheaper alternatives to DICLOXACILLIN 250 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of DICLOXACILLIN 250 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DICLOXACILLIN 250 MG CAPSULE?

DICLOXACILLIN 250 MG CAPSULE (NDC 00093312301) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.